Characteristics associated with naloxone infusion-related side effects
| Subject ID | Group | Sex | Weight | Symptoms | BP during baseline | BP during naloxone-induced side effects | HR during baseline | HR during naloxone-induced side effects |
|---|---|---|---|---|---|---|---|---|
| A | Meditation + naloxone | Female | 60.2 kg | Syncope, vomiting | 104/64 | 70/40 | 94 bpm | 74 bpm |
| B | Control + naloxone | Female | 57.4 kg | Cloudy vision, excessive perspiration, chest pressure | 112/66 | 69/41 | 65 bpm | 55 bpm |
| C | Control + naloxone | Female | 69.5 kg | Lightheadedness | 111/68 | 96/55 | 55 bpm | 85 bpm |
| D | Control + naloxone | Female | 46.7 kg | Lightheadedness | 116/71 | 85/59 | 74 bpm | 61 bpm |
BP, Blood pressure; HR, heart rate; bpm, beats per minute.